Bayer teams up with Huma to apply AI to lung cancer diagnosisA research project between Bayer and digital health company Huma will use artificial intelligence to detect lung cancer Share XBayer teams up with Huma to apply AI to lung cancer diagnosishttps://pharmaphorum.com/news/bayer-teams-up-with-huma-to-apply-ai-to-lung-cancer-diagnosis/
AI ‘could help diagnose lung cancer a year earlier’An artificial intelligence algorithm was able to detect signs of lung cancer on CT scans a year earlier Share XAI ‘could help diagnose lung cancer a year earlier’https://pharmaphorum.com/news/ai-could-help-diagnose-lung-cancer-a-year-earlier/
AI breast cancer screening ‘not accurate enough to replace humans’There is not enough evidence yet to allow artificial intelligence based breast cancer detection to be fully integrated Share XAI breast cancer screening ‘not accurate enough to replace humans’https://pharmaphorum.com/news/ai-breast-cancer-screening-not-accurate-enough-to-replace-humans/
J&J lung cancer initiative will use Optellum’s ‘digital biomarker’ techThree years ago, Johnson & Johnson set up a wide-ranging initiative with Boston University to try to improve Share XJ&J lung cancer initiative will use Optellum’s ‘digital biomarker’ techhttps://pharmaphorum.com/news/jj-teams-up-with-optellum-on-digital-biomarker-tech-lung-cancer/
Abbott bags FDA okay for AI-based heart imaging softwareThe FDA has approved an artificial intelligence-based imaging software developed by Abbott that is used to help physicians Share XAbbott bags FDA okay for AI-based heart imaging softwarehttps://pharmaphorum.com/news/abbott-bags-fda-okay-for-ai-based-heart-imaging-software/
Disney characters will lend a hand to kids during MRI scansRadiologists in Europe could soon have help keeping children calm as they have MRI scans from Disney favourites Share XDisney characters will lend a hand to kids during MRI scanshttps://pharmaphorum.com/news/disney-characters-will-lend-a-hand-to-kids-during-mri-scans/
Pfizer deal paves way for approval of ImaginAb’s cancer imaging techImaginAb has signed a deal with Pfizer, which it hopes will help it to gather information necessary for Share XPfizer deal paves way for approval of ImaginAb’s cancer imaging techhttps://pharmaphorum.com/news/pfizer-deal-could-help-approval-of-imaginabs-cancer-imaging-tech/
Roche, Blueprint raise pressure on Lilly with new Gavreto approvalThe FDA has cleared Roche and Blueprint Medicine’s Gavreto for a new use in RET-mutated thyroid cancer, putting Share XRoche, Blueprint raise pressure on Lilly with new Gavreto approvalhttps://pharmaphorum.com/news/roche-blueprint-raise-pressure-on-lilly-with-new-gavreto-approval/
AZ firms up immuno-oncology imaging deal with ImaginAbAstraZeneca has expanded its alliance with ImaginAb, an imaging specialist developing imaging agents to increase the efficacy and Share XAZ firms up immuno-oncology imaging deal with ImaginAbhttps://pharmaphorum.com/news/az-firms-up-immuno-oncology-imaging-deal-with-imaginab/
